Correction: Nordic Nanovector ASA: Invitation to attend R&D Day – clarification of CMO title
Oslo, Norway, 18 November 2021 Nordic Nanovector ASA (OSE: NANOV), a clinical stage biotechnology company developing targeted radiopharmaceuticals to extend and improve the lives of patients with haematological cancers, will host an R&D Day on Tuesday, 30 November 2021 starting at 14:00 CET/ 13:00 GMT/ 08:00 ET. The meeting will be held in person in Oslo and will also be available via a live webcast. The meeting, intended for investors and analysts, will provide an overview of the company’s vision, progress to date, development pipeline and corporate strategy. Presentations will be